X
X

Tom O'Brien

CEO

Prior to founding Eclipse in 1993, Tom held several leadership positions throughout his career in the medical device industry. Having mastered both disposable and capital equipment sales for companies like C.R. Bard, Tom’s track record of success quickly established Eclipse as the go-to company to launch new technology in the surgical laser industry.

Over time Tom transitioned Eclipse from a leader in the OR surgical laser market to a key player in the aesthetic laser industry. Starting in 2011 Eclipse began a new mission of increasing adoption of Platelet-rich Plasma on a national level.

His vision and leadership has helped Eclipse become one of the most successful medical device companies in its space. Tom’s new mission is to bring game-changing Eclipse technologies in Platelet-Rich Plasma, Microneedling and Shockwave Therapy to the entire globe.

X

Leading Edge Laser Technology Comes To Zimmet Vein and Dermatology

Steven E. Zimmet, M.D. Director of Zimmet Vein and Dermatology of Austin, Texas announces the introduction of the first Tri-Beam Q-Switch laser system available in Texas. The Tri-Beam Q-Switched Nd:YAG laser is specially designed for tattoo removal, treatment of pigmented lesions, melasma, acne, and non-ablative skin rejuvenation. The Tri-Beam also delivers a means to improve skin tone and texture. [link text=’Read More’ url=’http://www.bizjournals.com/dallas/prnewswire/press_releases/Georgia/2013/11/11/DA14720?ana=prnews’]

For USA & Canada visitors: EclipseMedGlobal.com is an international website that has not been evaluated by the United States Food and Drug Administration. Statements and/or claims on this site are not intended to prevent, diagnose, treat or cure any ailments or diseases. Information and product/packaging on this site is for informational purposes only and is not intended as a substitution for advice from a physician or health-care professional. Information shown on this site may describe clearances in countries other than the USA and Canada, hence it may include indications and information that are outside the scope of FDA-cleared labeling.

Do you understand and want to proceed?

 
Yes, please proceed

 

Visit the Eclipse USA Site